Encoding a secreted serine protease urokinase, PLAU has been attested to be associated with poor prognosis in HNSCC, the potential mechanism of which may be the dysfunction of the PI3K-Akt pathway and EMT process or aberrant proportions of immune cells (35, 36). Here, PLAU is linked to head and neck squamous cell carcinoma.